Go

Breaking News on Pharmaceutical Technology

All feeds

News headlines > Processing & QC

Handheld device for validating raw materials

29-Sep-2008 - Ahura Scientific has launched an updated version of its TruScan handheld instrument, which allows for raw materials to be quickly verified.

Pfizer’s API unit to use Prosonix' Prosonitron

24-Sep-2008 - Prosonix, a specialist developer of ultrasonic industrial processing solutions, says that global drug giant Pfizer is to begin using its Prosonitron reactor and sonocrystallisation technology at its manufacturing facility in Ireland.

Sandoz’ SA plant gets WHO NoC letter

23-Sep-2008 - The WHO has issued Sandoz with a Notice of Concern (NoC) after an inspection of the firm’s Kempton Park facility in South Africa identified 41 deviations from GMP standards.

DSM and LibraGen enter transaminase deal

22-Sep-2008 - Dutch chemicals giant DSM and France’s LibraGen are targeting the chemical and pharmaceutical industries with their new chiral amine production accord, which aims to develop a range of new catalytic enzymes.

EnWave’s new dehydration method shows promise

22-Sep-2008 - EnWave says that its freezeREV dehydration technology can reduce the moisture content of single vial vaccines to between 3 and 3.5 per cent, bettering the mark achieved by its bioREV platform.

Joint API inspection service to cut costs

22-Sep-2008 - Germany-based Diapharm has launched a service allowing pharmaceutical manufacturers to perform joint third-party audits of active pharmaceutical ingredients (APIs).

Capsugel targets toxics sector with vibration-free hood

18-Sep-2008 - Oral dose filling specialist Capsugel hopes that its new Xcelohood containment system will improve industrial weighing operations during the preparation of high-potency drugs.

FDA blocks imports from two Ranbaxy plants

17-Sep-2008 - The FDA has issued generics giant Ranbaxy Laboratories with two warning letters, detailing “extensive deviations from US cGMP requirements” at the firm’s manufacturing plants in Dewas and Paonta Sahib, India.

Millipore plans to close four facilities

16-Sep-2008 - Millipore is planning on closing four facilities, generating annual savings of up to $15m, as it attempts to cut costs by streamlining its operations.

Artelis and Selexis’ project achieves record MAb yield

16-Sep-2008 - Artelis president Jose Castilo believes that the record MAb yield from CHO cells grown in its iCELLis bioreactor shows the platform could shift the paradigm for the "production of recombinant proteins.”

New EC GMP regulations for radiopharma

15-Sep-2008 - Revised good manufacturing practice (GMP) requirements for the production of radiopharmaceuticals have been published by the European Commission (EC).

Residual solvents guidelines cause ANDA “uncertainty”

11-Sep-2008 - Companies have failed to provide the information needed under the USP’s new chapter regarding residual solvents, causing them to incorrectly file ANDAs, according to the Office of Generic Drugs (OGD).

Antibiotic alternative could make protein production cheaper

03-Sep-2008 - UK and Swedish researchers have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of biopharmaceutical products, making the process both safer and less costly.

Chromatide signs HPLC deal

02-Sep-2008 - UK-based polymer technology specialist Chromatide and Akzo Nobel's Separation Products (SP) unit are teaming to develop a HPLC media for purification applications in the drug manufacturing industry.

bioMerieux launches new clean room testing range

02-Sep-2008 - bioMerieux hopes that its new specially-packaged growth media products will help it “clean up” in the pharmaceutical industry’s lucrative sterility testing market

FDA warns Sandoz on unvalidated manufacturing

27-Aug-2008 - The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.

Actavis recalls all drugs made at New Jersey plant

06-Aug-2008 - Generic drugmaker Actavis Totowa has voluntarily recalled all drugs produced at its Little Falls, New Jersey manufacturing facility after an FDA inspection uncovered several breaches of current GMP codes.

Harro turns to Dyadem for risk management solution

04-Aug-2008 - Harro Hofliger’s adoption of the FMEA-Med software will help the German machining specialist minimize risk during development operations, according to Canadian developer Dyadem.

Syrris to tailor-make reactor systems

31-Jul-2008 - In response to high customer demand, leading automated chemistry systems manufacturer Syrris is now offering to build custom-made laboratory reactor systems designed to meet individual customer needs.

Bio-Rad takes the stress out of protein purification

31-Jul-2008 - Bio-Rad has published several application notes describing the use of its Profinity eXact protein expression system to obtain tag-free native proteins from a cell lysate in less than an hour.

Lotus' plant sows seeds for growth

29-Jul-2008 - Lotus Pharmaceuticals' plans for a RNM 160m ($23.4m) manufacturing facility in Inner Mongolia mark another milestone in the Chinese firm's expansion on the global drugmaking stage.

Lotus' plant sows seeds for growth

29-Jul-2008 - Lotus Pharmaceuticals' plans for a RNM 160m ($23.4m) manufacturing facility in Inner Mongolia mark another milestone in the Chinese firm's expansion on the global drugmaking stage.

Symyx’ Powdernium helps cut manufacturing costs

28-Jul-2008 - R&D integration specialist Symyx Technologies says its Powdernium Workstation is integral to the new automated dry powder dispensing system developed by a "major" but as yet unidentified pharmaceutical company.

ESA’s CAD improves detection of API impurities

23-Jul-2008 - UK-headquartered ESA Biosciences has unveiled a new technique for the identification of low levels organic impurities during the production of active pharmaceutical ingredients (API).

Upfront discusses MAb capture systems

17-Jul-2008 - With last month's launch of the Rhobust antibody capture system for MAb production applications, Upfront hopes to bring about a seismic shift in the MAb development paradigm.

Sign up for your free newsletter